Humoral Immune Response after anti-SARS-CoV-2 Vaccine "Booster" Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
Mediterr J Hematol Infect Dis
.
2023 Jan 1;15(1):e2023011.
doi: 10.4084/MJHID.2023.011.
eCollection 2023.
Authors
Nicola Sgherza
1
,
Paola Curci
1
,
Rita Rizzi
1
2
,
Angela Maria Vittoria Larocca
3
,
Luigi Vimercati
4
,
Silvio Tafuri
4
,
Maria Chironna
4
,
Pellegrino Musto
1
2
Affiliations
1
Hematology and Bone Marrow Transplantation Unit, AOUC Policlinico, Bari, Italy.
2
Department of Precision and Translational Medicine with Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy.
3
Hygiene Unit, AOUC, Policlinico Bari, Bari, Italy.
4
Interdisciplinary Department of Medicine, "Aldo Moro" University School of Medicine, Bari, Italy.
PMID:
36660353
PMCID:
PMC9833302
DOI:
10.4084/MJHID.2023.011
No abstract available
Keywords:
MGUS; Serological response; anti SARS-CoV-2 vaccine.